Accelerated course of experimental autoimmune encephalomyelitis in PD-1-deficient central nervous system myelin mutants

American Journal of Pathology

Volumn 174, Issue 6, 2009, Pages 2290-2299

  Kroner, Antje ^a   Schwab, Nicholas ^a   Chi, Wang Ip ^a   Ortler, Sonja ^a   Göbel, Kerstin ^a   Nave, Klaus Armin ^b   Mäurer, Mathias ^a,c   Martini, Rudolf ^a   Wiendl, Heinz ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

^c CARITAS KRANKENHAUS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MUTANT PROTEIN; MYELIN; MYELIN PROTEIN; PROGRAMMED DEATH MOLECULE 1; PROTEOLIPIDOPROTEIN; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CELL INFILTRATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DISEASE COURSE; DISEASE PREDISPOSITION; IMMUNE DYSREGULATION; MOUSE; MUTATION; NERVE FIBER DEGENERATION; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; RELAPSE; T LYMPHOCYTE;

EID: 67049142939     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2009.081012     Document Type: Article

References (41)

1. Frohman EM, Racke MK, Raine CS: Multiple sclerosis - the plaque and its pathogenesis. N Engl J Med 2006, 354:942-955
2. Wekerle H, Kojima K, Lannes-Vieira J, Lassmann H, Linington C: Animal models. Ann Neurol 1994, 36:S47-S53 (Pubitemid 24220843)
3. Steinman L: Assessment of animal models for MS and demyelinating disease in the design of rational therapy. Neuron 1999, 24:511-514
4. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL, Kuchroo VK: Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006, 441:235-238
5. Komiyama Y, Nakae S, Matsuki T, Nambu A, Ishigame H, Kakuta S, Sudo K, Iwakura Y: IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J Immunol 2006, 177:566-573 (Pubitemid 43939170)
6. Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H: Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 2000, 47:707-717 (Pubitemid 30390191)
7. Barnett MH, Prineas JW: Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann Neurol 2004, 55:458-468 (Pubitemid 38391962)
8. Warshawsky I, Rudick RA, Staugaitis SM, Natowicz MR: Primary progressive multiple sclerosis as a phenotype of a PLP1 gene mutation. Ann Neurol 2005, 58:470-473 (Pubitemid 41266636)
9. Gorman MP, Golomb MR, Walsh LE, Hobson GM, Garbern JY, Kinkel RP, Darras BT, Urion DK, Eksioglu YZ: Steroid-responsive neurologic relapses in a child with a proteolipid protein-1 mutation. Neurology 2007, 68:1305-1307 (Pubitemid 46625977)
10. Readhead C, Schneider A, Griffiths I, Nave KA: Premature arrest of myelin formation in transgenic mice with increased proteolipid protein gene dosage. Neuron 1994, 12:583-595 (Pubitemid 24100889)
11. Ip CW, Kroner A, Bendszus M, Leder C, Kobsar I, Fischer S, Wiendl H, Nave KA, Martini R: Immune cells contribute to myelin degeneration and axonopathic changes in mice overexpressing proteolipid protein in oligodendrocytes. J Neurosci 2006, 26:8206-8216 (Pubitemid 44315145)
12. Leder C, Schwab N, Ip CW, Kroner A, Nave KA, Dornmair K, Martini R, Wiendl H: Clonal expansions of pathogenic CD8+ effector cells in the CNS of myelin mutant mice. Mol Cell Neurosci 2007, 36:416-424 (Pubitemid 47633204)
13. Keir ME, Butte MJ, Freeman GJ, Sharpe AH: PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol 2008, 26:677-704 (Pubitemid 351600389)
14. Keir ME, Liang SC, Guleria I, Latchman YE, Qipo A, Albacker LA, Koulmanda M, Freeman GJ, Sayegh MH, Sharpe AH: Tissue expression of PD-L1 mediates peripheral T cell tolerance. J Exp Med 2006, 203:883-895
15. Grabie N, Gotsman I, DaCosta R, Pang H, Stavrakis G, Butte MJ, Keir ME, Freeman GJ, Sharpe AH, Lichtman AH: Endothelial programmed death-1 ligand 1 (PD-L1) regulates CD8+ T-cell mediated injury in the heart. Circulation 2007, 116:2062-2071 (Pubitemid 350023752)
16. Dong H, Zhu G, Tamada K, Flies DB, van Deursen JM, Chen L: B7-H1 determines accumulation and deletion of intrahepatic CD8(+) T lymphocytes. Immunity 2004, 20:327-336 (Pubitemid 38388234)
17. Magnus T, Schreiner B, Korn T, Jack C, Guo H, Antel J, Ifergan I, Chen L, Bischof F, Bar-Or A, Wiendl H: Microglial expression of the B7 family member B7 homolog 1 confers strong immune inhibition: implications for immune responses and autoimmunity in the CNS. J Neurosci 2005, 25:2537-2546 (Pubitemid 40365165)
18. Latchman Y, Wood CR, Chernova T, Chaudhary D, Borde M, Chernova I, Iwai Y, Long AJ, Brown JA, Nunes R, Greenfield EA, Bourque K, Boussiotis VA, Carter LL, Carreno BM, Malenkovich N, Nishimura H, Okazaki T, Honjo T, Sharpe AH, Freeman GJ: PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat Immunol 2001, 2:261-268 (Pubitemid 33706004)
19. Nishimura H, Nose M, Hiai H, Minato N, Honjo T: Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 1999, 11:141-151 (Pubitemid 29428807)
20. Nishimura H, Okazaki T, Tanaka Y, Nakatani K, Hara M, Matsumori A, Sasayama S, Mizoguchi A, Hiai H, Minato N, Honjo T: Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science 2001, 291:319-322 (Pubitemid 32096320)
21. Salama AD, Chitnis T, Imitola J, Ansari MJ, Akiba H, Tushima F, Azuma M, Yagita H, Sayegh MH, Khoury SJ: Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis. J Exp Med 2003, 198:71-78 (Pubitemid 36870187)
22. Carter LL, Leach MW, Azoitei ML, Cui J, Pelker JW, Jussif J, Benoit S, Ireland G, Luxenberg D, Askew GR, Milarski KL, Groves C, Brown T, Carito BA, Percival K, Carreno BM, Collins M, Marusic S: PD-1/PD-L1, but not PD-1/PD-L2, interactions regulate the severity of experimental autoimmune encephalomyelitis. J Neuroimmunol 2007, 182:124-134 (Pubitemid 46039761)
23. Kroner A, Schwab N, Ip CW, Sommer C, Wessig C, Wiendl H, Martini R: The co-inhibitory molecule PD-1 modulates disease severity in a model for an inherited, demyelinating neuropathy. Neurobiol Dis 2009, 33:96-103
24. Kroner A, Schwab N, Ip CW, Leder C, Nave KA, Maurer M, Wiendl H, Martini R: PD-1 regulates neural damage in oligodendroglia-induced inflammation. PLoS ONE 2009, 4:e4405
25. Fife BT, Guleria I, Gubbels Bupp M, Eagar TN, Tang Q, Bour-Jordan H, Yagita H, Azuma M, Sayegh MH, Bluestone JA: Insulin-induced remission in new-onset NOD mice is maintained by the PD-1-PD-L1 pathway. J Exp Med 2006, 203:2737-2747 (Pubitemid 44833349)
26. Wang J, Yoshida T, Nakaki F, Hiai H, Okazaki T, Honjo T: Establishment of NOD-Pdcd1-/- mice as an efficient animal model of type I diabetes. Proc Natl Acad Sci USA 2005, 102:11823-11828 (Pubitemid 41170809)
27. Ito T, Ueno T, Clarkson MR, Yuan X, Jurewicz MM, Yagita H, Azuma M, Sharpe AH, Auchincloss Jr H, Sayegh MH, Najafian N: Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo. J Immunol 2005, 174:6648-6656 (Pubitemid 40705625)
28. Kroner A, Mehling M, Hemmer B, Rieckmann P, Toyka KV, Maurer M, Wiendl H: A PD-1 polymorphism is associated with disease progression in multiple sclerosis. Ann Neurol 2005, 58:50-57 (Pubitemid 40962460)
29. Ortler S, Leder C, Mittelbronn M, Zozulya AL, Knolle PA, Chen L, Kroner A, Wiendl H: B7-H1 restricts neuroantigen-specific T cell responses and confines inflammatory CNS damage: implications for the lesion pathogenesis of multiple sclerosis. Eur J Immunol 2008, 38:1734-1744
30. Schreiner B, Bailey SL, Shin T, Chen L, Miller SD: PD-1 ligands expressed on myeloid-derived APC in the CNS regulate T-cell responses in EAE. Eur J Immunol 2008, 38:2706-2717
31. Nishimura H, Minato N, Nakano T, Honjo T: Immunological studies on PD-1 deficient mice: implication of PD-1 as a negative regulator for B cell responses. Int Immunol 1998, 10:1563-1572 (Pubitemid 28451451)
32. Ip CW, Kroner A, Crocker PR, Nave KA, Martini R: Sialoadhesin deficiency ameliorates myelin degeneration and axonopathic changes in the CNS of PLP overexpressing mice. Neurobiol Dis 2007, 25:105-111 (Pubitemid 44765220)
33. Pannetier C, Even J, Kourilsky P: T-cell repertoire diversity and clonal expansions in normal and clinical samples. Immunol Today 1995, 16:176-181
34. Begolka WS, Vanderlugt CL, Rahbe SM, Miller SD: Differential expression of inflammatory cytokines parallels progression of central nervous system pathology in two clinically distinct models of multiple sclerosis. J Immunol 1998, 161:4437-4446 (Pubitemid 28469031)
35. McMahon EJ, Bailey SL, Castenada CV, Waldner H, Miller SD: Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. Nat Med 2005, 11:335-339 (Pubitemid 40460563)
36. Fazilleau N, Delarasse C, Motta I, Fillatreau S, Gougeon ML, Kourilsky P, Pham-Dinh D, Kanellopoulos JM: T cell repertoire diversity is required for relapses in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis. J Immunol 2007, 178:4865-4875 (Pubitemid 46595268)
37. Menezes JS, van den Elzen P, Thornes J, Huffman D, Droin NM, Maverakis E, Sercarz EE: A public T cell clonotype within a heterogeneous autoreactive repertoire is dominant in driving EAE. J Clin Invest 2007, 117:2176-2185 (Pubitemid 47219562)
38. Bettelli E, Pagany M, Weiner HL, Linington C, Sobel RA, Kuchroo VK: Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J Exp Med 2003, 197:1073-1081 (Pubitemid 36570063)
39. Friese MA, Fugger L: Autoreactive CD8+ T cells in multiple sclerosis: a new target for therapy? Brain 2005, 128:1747-1763
40. Lassmann H: Experimental models of multiple sclerosis. Rev Neurol (Paris) 2007, 163:651-655 (Pubitemid 47015564)
41. Werner P, Pitt D, Raine CS: Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage. Ann Neurol 2001, 50:169-180 (Pubitemid 32738141)